Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

FORM 10-Q

 

 

 

[Mark One]

 

 

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended March 31, 2003

 

OR

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the transition period from           to           

 

Commission File Number 0-23315

 

enherent Corp.

 

Delaware

 

No. 13-3914972

(State or other jurisdiction of incorporation)

 

(I.R.S. Employer Identification Number)

 

80 Lamberton Road
Windsor, CT 06095

(Address of principal executive offices)

 

(860) 687-2200

(Telephone number, including area code)

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES  ý                                NO o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  YES  o  NO  ý

 

Indicate the number of share outstanding of each of the issuer’s classes of common stock:

 

Class

 

Shares outstanding as of May 9, 2002

Common stock, par value $.001

 

17,502,188

 

 



 

enherent Corp. and Subsidiaries

 

INDEX

 

PART I.  FINANCIAL INFORMATION

 

Item 1.  Financial Statements.

 

Consolidated Balance Sheets as of March 31, 2003 and December 31, 2002

 

Consolidated Statements of Operations for the three months ended March 31, 2003 and 2002

 

Consolidated Statements of Cash Flows for the three months ended March 31, 2003 and 2002

 

Notes to Consolidated Financial Statements

 

Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Item 3.  Quantitative and Qualitative Disclosures about Market Risk.

 

Item 4.  Controls and Procedures.

 

PART II.  OTHER INFORMATION

 

Item 1.  Legal Proceedings

 

Item 5.  Other Information

 

Item 6.  Exhibits and Reports on Form 8-K

 

Signatures

 

CEO Certification

 

CFO Certification

 

Exhibit Index

 



 

Item 1. Financial Statements

 

enherent Corp. and Subsidiaries

Consolidated Balance Sheets

(In thousands, except number of shares)

 

 

 

March 31,
2003

 

December 31,
2002

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and equivalents

 

$

2,467

 

$

3,067

 

Accounts receivable, net of allowance of $48 at March 31, 2003 and $57 at December 31, 2002

 

1,940

 

1,926

 

Prepaid expenses and other current assets

 

220

 

259

 

Total current assets

 

4,627

 

5,252

 

 

 

 

 

 

 

Fixed assets, net

 

358

 

477

 

Other assets

 

63

 

69

 

Total assets

 

$

5,048

 

$

5,798

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accrued compensation

 

$

340

 

$

283

 

Accounts payable

 

422

 

470

 

Accrued expenses

 

193

 

294

 

Current portion of capital lease obligations

 

9

 

14

 

Deferred revenue

 

32

 

171

 

Total current liabilities

 

996

 

1,232

 

 

 

 

 

 

 

Capital lease obligations, net of current portion

 

4

 

5

 

Deferred rent

 

51

 

58

 

Total liabilities

 

1,051

 

1,295

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

Series A senior participating redeemable convertible preferred stock, $0.001 par value; authorized-10,000,000 shares; issued and outstanding-7,000,000 shares at March 31, 2003 and December 31, 2002

 

5,689

 

5,553

 

 

 

 

 

 

 

Common stockholders’ equity (deficit):

 

 

 

 

 

Common stock, $0.001 par value; authorized-50,000,000 shares; issued-19,351,311 shares; outstanding-17,502,188 shares at March 31, 2003 and December 31, 2002

 

19

 

19

 

Additional paid-in capital

 

94,411

 

94,411

 

Treasury stock, at cost-1,849,123 shares at March 31, 2003 and December 31, 2002

 

(366

)

(366

)

Accumulated deficit

 

(95,756

)

(95,114

)

Total common stockholders’ equity (deficit)

 

(1,692

)

(1,050

)

Total liabilities and stockholders’ equity

 

$

5,048

 

$

5,798

 

 

See accompanying notes.

 

1



 

enherent Corp. and Subsidiaries

Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended March 31,

 

 

 

2003

 

2002

 

 

 

 

 

 

 

Revenues

 

$

3,653

 

$

5,916

 

Cost of revenues

 

2,915

 

4,724

 

Gross profit

 

738

 

1,192

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

1,248

 

2,988

 

Loss from operations

 

(510

)

(1,796

)

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

Miscellaneous income (expense)

 

3

 

 

Interest expense

 

(2

)

(5

)

Interest income

 

3

 

16

 

Net loss

 

(506

)

(1,785

)

Preferred stock accretion net of benefit to common shareholders

 

(136

)

400

 

Net loss available to common stockholders

 

$

(642

)

$

(1,385

)

 

 

 

 

 

 

Basic and diluted net loss per share applicable to common stockholders

 

$

(.04

)

$

(.08

)

Number of shares used in computing  basic and diluted  net loss per share

 

17,502

 

17,502

 

 

See accompanying notes.

 

2



 

enherent Corp. and Subsidiaries

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Three Months Ended March 31,

 

 

 

2003

 

2002

 

Cash flows from operating activities

 

 

 

 

 

Net loss

 

$

(506

)

$

(1,785

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation and amortization

 

102

 

230

 

Provision (credit) for doubtful accounts

 

(9

)

12

 

Loss on disposal of fixed assets

 

12

 

 

Deferred rent

 

(8

)

(9

)

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(5

)

(183

)

Prepaid expenses and other current assets

 

39

 

41

 

Other assets

 

6

 

11

 

Accrued compensation

 

57

 

(86

)

Accounts payable

 

(48

)

177

 

Accrued expenses

 

(101

)

342

 

Deferred revenue

 

(139

)

(42

)

Net cash used in operating activities

 

(600

)

(1,292

)

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Purchases of fixed assets

 

 

(14

)

Proceeds from sale of fixed assets

 

5

 

 

Net cash provided by (used in) investing activities

 

5

 

(14

)

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Purchase of treasury stock

 

 

(200

)

Principal payments under capital lease obligations

 

(5

)

(6

)

Net cash used in financing activities

 

(5

)

(206

)

 

 

 

 

 

 

Net decrease in cash and equivalents

 

(600

)

(1512

)

Cash and equivalents at beginning of period

 

3,067

 

5,269

 

Cash and equivalents at end of period

 

$

2,467

 

$

3,757

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information

 

 

 

 

 

Interest paid

 

$

2

 

$

5

 

 

See accompanying notes.

 

3



 

enherent Corp.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1.               Basis of Presentation

 

The unaudited consolidated financial statements presented herein have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Item 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.  In the opinion of management, the accompanying consolidated financial statements include all adjustments (consisting only of normal recurring entries, except as disclosed) considered necessary for a fair presentation of the financial condition and results of operations for the periods presented.  The results of operations for the three-month period ended March 31, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003. The statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the enherent Corp. (the “Company”) Annual Report on Form 10-K for the year ended December 31, 2002.

 

The Company anticipates that its primary uses of working capital in the near term will be to fund the Company’s operations.  Management believes that the cash equivalents are sufficient to fund operations for the next 12 months.  If cash generated from operations is insufficient to satisfy the Company’s liquidity requirements, the Company may in the future be required to seek additional sources of financing. If the Company is unsuccessful in obtaining additional sources of financing, the Company could experience difficulty meeting its current obligations as they become due.

 

2.               Principles of Consolidation

 

The accompanying financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant intercompany balances and transactions have been eliminated in consolidation.

 

3.               Series A Senior Participating Redeemable Convertible Preferred Stock

 

On January 30, 2002, with the approval of its Board of Directors, enherent entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with The Travelers Indemnity Company (“The Travelers”), pursuant to which The Travelers converted 1,000,000 shares of its Series A Senior Participating Redeemable Convertible Preferred Stock into 1,000,000 shares of enherent Common Stock. Under

 

4



 

the terms of the Stock Purchase Agreement, The Travelers then sold the 1,000,000 shares of Common Stock to enherent for $200,000.  enherent has retired the 1,000,000 shares of Series A Senior Participating Redeemable Convertible Preferred Stock. The Preferred Stock was carried at approximately $720,000 at the date of the transaction.  Because the Common Stock was purchased below the carrying value of the Preferred Stock, a benefit to common shareholders of approximately $527,000 was recorded. The remaining Preferred Stock is being accreted to its liquidation value at April 12, 2005. Accretion of approximately $136,000 and $127,000 was recorded in the three-month periods ending March 31, 2003 and 2002, respectively.

 

4.               Loss Per Share

 

The following sets forth the computation of basic and diluted loss per share (in thousands, except per share data):

 

 

 

Three months ended March 31,

 

 

 

2003

 

2002

 

Numerator:

 

 

 

 

 

Net loss applicable to common shareholders

 

$

(642

)

$

(1,385

)

Denominator:

 

 

 

 

 

Weighted average shares outstanding

 

17,502

 

17,502

 

Basic and diluted loss per share

 

$

(.04

)

$

(.08

)

 

The Company has excluded the impact of the redeemable convertible preferred stock and related warrants and stock options outstanding under the Company’s stock option plan as the effect would be anti-dilutive.

 

5.               Stock-Based Compensation

 

The Company accounts for stock options using the intrinsic value method set forth in Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees” and accordingly, recognizes compensation expense only if the fair value of the underlying Common Stock exceeds the exercise price of the stock option on the date of grant. As permitted by Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation” (“SFAS 123”), the Company continues to account for stock-based compensation in accordance with APB Opinion No. 25 and has elected the pro forma disclosure alternative of SFAS No. 123.

 

The following table illustrates the effect on net loss and loss per share if we applied the fair value recognition provisions of SFAS 123 instead of APB Opinion No. 25’s intrinsic value method to account for stock-based employee compensation (in thousands, except per share amounts):

 

5



 

 

 

 

Three months ended March 31,

 

 

 

2003

 

2002

 

Net loss available to common stockholders as reported

 

$

(642

)

$

(1,385

)

Total stock option expense determined under fair value base method

 

(87

)

(343

)

Pro forma net earnings

 

$

(729

)

$

(1,728

)

Net loss per common share as reported: basic and diluted

 

$

(.04

)

$

(.08

)

Net loss per common share pro forma: basic and diluted

 

$

(.04

)

$

(.10

)

 

Pro forma information regarding net income (loss) and earnings (loss) per share is required by SFAS No. 123 and has been determined as if the Company had accounted for its employees’ stock options under the fair value method provided by that Statement. The fair value of the options was estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions for vested and non-vested options:

 

 

 

March 31,

 

Assumption

 

2003

 

2002

 

 

 

 

 

 

 

Risk-free interest rate

 

 

2.99

%

Dividend yield

 

0

%

0

%

Volatility factor of the expected market price of the Company’s Common Stock

 

1.29

 

1.40

 

Average life

 

5 years

 

5 years

 

 

6.               Office Closures

 

The Company plans to close its Dallas office in the third quarter of 2003 to reduce costs and increase efficiency. In accordance with Statement of Financial Accounting Standards No. 146 (“SFAS 146”), “Accounting for Costs Associated with Exit or Disposal Activities,” costs associated with training personnel, travel, moving expenses and duplicate facility costs will be expensed when incurred and are expected to total approximately $115,000.  The total benefits costs consisting of severance and stay bonuses for six administrative personnel of $113,000, for which employees are required to render service until they are terminated in order to receive the termination benefit, are being recognized ratably over the service period. The Company has recorded a charge in the three-month period ended March 31, 2003 of approximately $56,000 for severance and stay bonuses. The Company estimates the total closure costs at approximately $228,000.  These costs will be paid in the second and third quarters of 2003.

 

6



 

7.               Contingencies

 

In the normal course of business, various claims are made against the Company.  At this time, in the opinion of management, there are no pending claims the outcome of which are expected to result in a material adverse effect on the consolidated financial position or results of operations of the Company.

 

Item 2.              Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Results of Operations

 

Revenue.  Revenues decreased $2.2 million during the three-month period ended March 31, 2003 to $3.7 million compared to $5.9 million for the three-month period ended March 31, 2002. The decrease in revenue was a result of the completion of client projects, non-renewal of certain client assignments and billing rate reductions.

 

Cost of Revenues.  Cost of revenues decreased $1.8 million to $2.9 million for the three-month period ended March 31, 2003 from $4.7 million in the comparable period in 2002. The decrease in cost of revenues was attributable to the overall decrease in revenues.  Cost of revenues as a percentage of revenues remained approximately 80% for the three-month period ended March 31, 2003 when compared to the three-month period ended March 31, 2002.

 

Gross Profit.  Gross profit as a percentage of revenues remained approximately 20% in the three-month period ended March 31, 2003 when compared to the three-month period ended March 31, 2002.

 

Selling, General & Administrative (SG&A) Expenses.  SG&A expenses decreased approximately 58% to $1.2 million in the three-month period ended March 31, 2003 from $3.0 million for the comparable period in 2002.  SG&A as a percentage of revenue decreased to 34% for the three-month period ended March 31, 2003 from 51% for the comparable period in 2002.  The decrease in SG&A expenses was attributable to the impact of the closure of the Barbados Solution Center totaling approximately $475,000, the settlement of a lawsuit of approximately $275,000 and cost-cutting measures, including staffing reductions, of approximately $1 million.

 

Loss from Operations.  For the reasons set forth above, loss from operations for the three months ended March 31, 2003 decreased to $.5 million as compared to a loss from operations of $1.8 million in the comparable period in 2002.  As a percentage of revenues, the loss from operations for the three months ended March 31, 2003 decreased to 14% as compared to approximately 30% in the comparable period in 2002.

 

7



 

Preferred Stock Dividends and Accretion Net of Benefit to Common Shareholders. Accretion on the preferred stock was approximately $136,000 for the three-month period ended March 31, 2003 and approximately $127,000 in the comparable period in 2002.  In the three-month period ended March 31, 2002, the Company recorded a benefit to common shareholders of approximately $527,000 related to the stock purchase agreement with the Travelers (see footnote 3).

 

Liquidity and Capital Resources

 

Working Capital: The Company’s working capital decreased to approximately $3.6 million at March 31, 2003 from $4.0 million at December 31, 2002.  Cash and cash equivalents were $2.5 million at March 31, 2003 compared to $3.1 million at December 31, 2002.  The primary use of cash during the three months ended March 31, 2003 was to fund operating activities of approximately $.5 million. The Company’s accounts receivables were $1.9 million at March 31, 2003 and at December 31, 2002.  Billed days sales outstanding, net of allowance for doubtful accounts, was 48 days at March 31, 2003 and 40 days at December 31, 2002.

 

The Company anticipates that its primary uses of cash in the near term will be to fund the Company’s operations.  Management believes that the cash equivalents are sufficient to fund operations for the next 12 months.  If cash generated from operations is insufficient to satisfy the Company’s liquidity requirements, the Company may in the future be required to seek additional sources of financing. If the Company is unsuccessful in obtaining additional sources of financing, the Company could experience difficulty meeting its current obligations as they become due.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

For the period ended March 31, 2003, the Company did not experience any material changes in market risk exposures that affect the quantitative and qualitative disclosures presented in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosures Controls and Procedures

 

The Company’s Chief Executive Officer and Chief Financial Officer, after evaluating the Company’s “disclosure controls and procedures” (as defined in Securities Exchange Act Rules 13a-14(c) and 15d-14(c)) as of March 31, 2003 (the “Evaluation Date”), each has concluded that as of the Evaluation Date, the Company’s disclosure controls and procedures were adequate and designed to ensure that material information relating to the

 

8



 

Company and its consolidated subsidiaries would be made known to them by others within those entities.

 

Changes in Internal Controls

 

Subsequent to the Evaluation Date, there were no significant changes in the Company’s internal controls or, to the Company’s knowledge, in other factors that could significantly affect the Company’s disclosure controls and procedures.

 

9



 

PART II.  OTHER INFORMATION

 

Item 1.  Legal Proceedings.

 

In the normal course of business, various claims are made against the Company. At this time, in the opinion of management, there are no pending claims the outcome of which are expected to result in a material adverse effect on the consolidated financial position or results of operations of the Company.

 

Item. 5.  Other Information.

 

Effective November 1, 2002, the Company entered into an employment agreement with Robert D. Merkl for a fourteen (14) month term (the “Merkl Agreement”) commencing on November 1, 2002.

 

Under the Merkl Agreement, Mr. Merkl serves as Chairman, Chief Executive Officer and President, earning a base salary of $192,000, with a target bonus opportunity of $96,000.  In April 2003, Mr. Merkl received a $24,000 performance bonus under the terms of the Merkl Agreement based on the Company’s performance during the fourth quarter of 2002.  The annual base salary will be reviewed annually by the Board of Directors and increased (but not decreased) if the Board of Directors, in its discretion, determines such an increase to be appropriate.

 

If Mr. Merkl’s employment is terminated (i) by the Company Without Cause (as defined in the Merkl Agreement), prior to the expiration of the term of the Merkl Agreement, the Company shall pay Mr. Merkl (i) his current annual base salary for eight (8) months, and; (ii) any earned performance bonus prorated as of the date of termination.  Payment will be made in accordance with the Company’s current payroll practices.  Additionally, if Mr. Merkl’s employment is terminated by the Company Without Cause, (i) any incentive stock options held by Mr. Merkl shall immediately vest and remain exercisable in accordance with the terms of the Company’s Amended and restated 1996 Stock Option Plan (the “Plan”) and the applicable option grant and (ii) any non-qualified stock options granted to Mr. Merkl that are vested at the date of termination shall be exercisable as per the Plan and the applicable option grant.  Non-qualified options that are not vested at the date of termination shall expire.

 

If Mr. Merkl’s employment is terminated by Mr. Merkl for Good Reason (as defined in the Merkl Agreement), the Company shall pay Mr. Merkl the same amounts as would have been paid had his employment been terminated Without Cause (as defined in the Merkl Agreement).  “Good Reason” includes a material diminution in Mr. Merkl’s

 

10



 

position, authorities, duties or responsibilities, a material breach by the Company of its obligations under the Merkl Agreement and a termination by the Company of Mr. Merkl’s employment following a Change in Control (as defined in the Merkl Agreement) prior to the expiration of the term of the Merkl Agreement and within six (6) months of the Change in Control.  The Merkl Agreement provides that in the event of a Change in Control of the Company, incentive options held by Mr. Merkl shall immediately vest and remain exercisable in accordance with the terms of the Plan.  All nonqualified options held by Mr. Merkl at the date of the Change in Control that are vested at that date are to remain exercisable in accordance with the terms of the Plan, and all such non-qualified options that are not vested at the date of the Change in Control shall expire.  At its option, in the event of a Change in Control, the Company may elect to exchange any such vested option for cash or a replacement award of equivalent value.

 

During his employment with the Company, Mr. Merkl has been awarded options to purchase 640,000 shares of the Company’s Common Stock, the strike prices of which are 5,000 shares at $1.125, 5,000 shares at $0.6875, 30,000 shares at $0.625, 100,000 shares at $0.10, and 500,000 shares at $0.025.

 

11



 

Item 6. Exhibits and Reports on Form 8-K

 

(a)           Exhibits

 

The following is a list of exhibits filed as part of this quarterly report on Form 10-Q:

 

Exhibit
No.

 

Description of Exhibits

3.1

 

Restated Certificate of Incorporation (Incorporated by reference to Exhibit 4.1 of the Company’s Form S-8 filed January 22, 1998).

3.2

 

Certificate of Amendment of Restated Certificate of Incorporation of enherent Corp. (Incorporated by reference to Exhibit 3.1 of the Company’s Annual Report on Form 10-K filed April 4, 2001).

3.3

 

Amended and Restated Bylaws (Incorporated by reference to Exhibit 4.2 of the Company’s Form S-8 filed January 22, 1998).

4.1

 

Form of Certificate of Common Stock (Incorporated by reference to Exhibit 4.1 of the Company’s Annual Report on Form 10-K filed March 22, 2002).

4.2

 

Securities Purchase Agreement dated April 13, 2000, by and among PRT Group Inc. and the Investors named therein (Incorporated by reference to Exhibit 99.1 of the Company’s  Form 8-K filed April 14, 2000).

4.3

 

Form of Certificate of Designations (Incorporated by reference to Exhibit 99.2 of the Company’s Form 8-K filed April 14, 2000).

4.4

 

Form of Warrant  (Incorporated by reference to Exhibit 99.3 of the Company’s  form 8-K filed April 14, 2000).

10.1

 

Employment Agreement between Robert D. Merkl and the Company dated November 1, 2002 (Filed herewith).

99.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

99.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

 

(b)          Reports on Form 8-K

 

None.

 

12



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

enherent Corp.

 

 

 

 

 

 

 

 

DATE

May 14, 2003

 

BY

/s/ Robert D. Merkl

 

 

 

Robert D. Merkl

 

 

 

Chief Executive Officer

 

 

 

 

 

 

 

 

DATE

May 14, 2003

 

BY

/s/ George Warman

 

 

 

George Warman

 

 

 

Chief Financial Officer

 

13



 

CERTIFICATION

 

I, Robert D. Merkl, certify that:

 

1.               I have reviewed this Quarterly Report on Form 10-Q of enherent Corp.,

 

2.               Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.               Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Quarterly Report;

 

4.               The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a﷓14 and 15d﷓14) for the registrant and we have:

 

a.               designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

b.              evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this Quarterly Report (the “Evaluation Date”); and

 

c.               presented in this Quarterly Report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

5.               The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a.               all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b.              any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

14



 

6.               The registrant’s other certifying officers and I have indicated in this Quarterly Report whether or not there were significant changes in internal controls or in other factors that could significantly affect controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

 

/S/ ROBERT D. MERKL

 

Robert D. Merkl

 

Chairman of the Board, President and
Chief Executive Officer

 

enherent Corp.

 

May 14, 2003

 

 

15



 

CERTIFICATION

 

I, George Warman, certify that:

 

1.               I have reviewed this Quarterly Report on Form 10-Q of enherent Corp.;

 

2.               Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.               Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Quarterly Report;

 

4.               The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a﷓14 and 15d﷓14) for the registrant and we have:

 

a.               designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

b.              evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this Quarterly Report (the “Evaluation Date”); and

 

c.               presented in this Quarterly Report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

5.               The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a.               all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b.              any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

16



 

6.               The registrant’s other certifying officers and I have indicated in this Quarterly Report whether or not there were significant changes in internal controls or in other factors that could significantly affect controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

 

/S/ GEORGE WARMAN

 

George Warman

Chief Financial Officer

enherent Corp.

May 14, 2003

 

17



 

 

Exhibit Index:

 

Exhibit
No.

 

Description of Exhibits

3.1

 

Restated Certificate of Incorporation (Incorporated by reference to Exhibit 4.1 of the Company’s Form S-8 filed January 22, 1998).

3.2

 

Certificate of Amendment of Restated Certificate of Incorporation of enherent Corp. (Incorporated by reference to Exhibit 3.1 of the Company’s Annual Report on Form 10-K filed April 4, 2001).

3.3

 

Amended and Restated Bylaws (Incorporated by reference to Exhibit 4.2 of the Company’s Form S-8 filed January 22, 1998).

4.1

 

Form of Certificate of Common Stock (Incorporated by reference to Exhibit 4.1 of the Company’s Annual Report on Form 10-K filed March 22, 2002).

4.2

 

Securities Purchase Agreement dated April 13, 2000, by and among PRT Group Inc. and the Investors named therein (Incorporated by reference to Exhibit 99.1 of the Company’s  Form 8-K filed April 14, 2000).

4.3

 

Form of Certificate of Designations (Incorporated by reference to Exhibit 99.2 of the Company’s Form 8-K filed April 14, 2000).

4.4

 

Form of Warrant  (Incorporated by reference to Exhibit 99.3 of the Company’s  form 8-K filed April 14, 2000).

10.1

 

Employment Agreement between Robert D. Merkl and the Company dated November 1, 2002 (Filed herewith).

99.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

99.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith).

 

18